Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development
Aiforia Technologies Plc, Company release, 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development.The estimated cost for the project is EUR 14,6 million for two years, of which Business Finland will fund a maximum of 50% (EUR 7,3 million) in the form of a loan. "The growing global market will need the expertise, advanced technologies, and digital solutions of Finnish companies and research organizations. Aiforia is a pioneer in its field